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Abstract
Background
Existing evidence on the effects of smoke-free policies on respiratory diseases is scarce
and inconclusive. Spain enacted two consecutive smoke-free regulations: a partial ban in
2006 and a comprehensive ban in 2011. We estimated their impact on hospital admissions
via emergency departments for chronic obstructive pulmonary disease (COPD) and
asthma.
Methods
Data for COPD (ICD-9 490–492, 494–496) came from 2003–2012 hospital admission rec-
ords from the fourteen largest provinces of Spain and from five provinces for asthma (ICD-9
493). We estimated changes in hospital admission rates within provinces using Poisson
additive models adjusted for long-term linear trends and seasonality, day of the week, tem-
perature, influenza, acute respiratory infections, and pollen counts (asthma models). We
estimated immediate and gradual effects through segmented-linear models. The coeffi-
cients within each province were combined through random-effects multivariate meta-ana-
lytic models.
Results
The partial ban was associated with a strong significant pooled immediate decline in COPD-
related admission rates (14.7%, 95%CI: 5.0, 23.4), sustained over time with a one-year
decrease of 13.6% (95%CI: 2.9, 23.1). The association was consistent across age and sex
groups but stronger in less economically developed Spanish provinces. Asthma-related
admission rates decreased by 7.4% (95%CI: 0.2, 14.2) immediately after the comprehen-
sive ban was implemented, although the one-year decrease was sustained only among
men (9.9%, 95%CI: 3.9, 15.6).
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Conclusions
The partial ban was associated with an immediate and sustained strong decline in COPD-
related admissions, especially in less economically developed provinces. The comprehen-
sive ban was related to an immediate decrease in asthma, sustained for the medium-term
only among men.
Introduction
Ample evidence links environmental exposure to second-hand tobacco smoke (SHS) to sub-
stantial harmful health effects, particularly to cardiovascular and respiratory systems [1,2].
Nevertheless, though SHS contains potent irritants which may lead to chronic inflammation
and airway obstruction, current evidence is suggestive but not sufficient to infer a causal rela-
tionship between SHS exposure and the onset of asthma or chronic obstructive pulmonary dis-
ease (COPD) [1,2,3].
A wealth of research has evaluated the heath impact of the implementation of smoke-free
laws. Several studies have examined outcomes based on changes in several respiratory symptoms
among hospitality workers before and after the implementation of smoking bans. Based on
questionnaire data [4–6] or pulmonary function tests [6] the evidence shows symptom reduc-
tion and improvements in pulmonary function parameters. Other studies have examined
changes in the volume of hospital admissions with inconclusive results [7]; some show a reduc-
tion in hospitalizations for COPD [8–13], whereas others fail to detect any significant differences
[14–16]. Similarly, most studies on asthma-related hospital admissions reported a reduction in
hospitalizations [10,12,14,16–22], but others observed no significant changes [11,15].
In Spain smoke-free regulations have been introduced consecutively. The first law came
into force on the 1st of January of 2006 (partial ban) dictating a complete smoking ban at the
workplace and a partial ban in hospitality venues (cafe´s, eateries, bars, and restaurants (bar
and restaurants from now on) where partial restrictions applied according to venue size. Ven-
ues larger than 100m2 had to be 100% smoke-free or establish a physically separated smoking
section (with its own ventilation system) not to exceed 30% of the total surface. Owners of
smaller venues could continue allowing tobacco consumption, just as before the ban, or desig-
nate their venue as 100% smoke-free. This regulation achieved an important reduction in
workplace-related SHS exposure but the impact was very modest in bars and restaurants [23].
To further reduce SHS exposure, a reform of the smoking legislation took effect on January
1st of 2011 banning tobacco consumption in virtually all public spaces (comprehensive ban),
including hospitality venues regardless of size. The new regulation eliminated all exceptions
for hospitality venues drastically reducing SHS exposure in bars and restaurants [24]. Contrary
to the industry´s fears, this ban had no negative impact on consumer expenditures in hospital-
ity venues [25].
The main aim of the present work was to assess the joint association of two consecutive
smoking bans and hospital admissions via emergency departments due to COPD and asthma
using a large sample of the Spanish population.
Material and methods
Study population and data source
The study was conducted in the fourteen largest provinces of Spain for COPD, and in five
provinces for asthma (see Table 1 for a list of the provinces included in each model). These
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provinces cover approximately 62% and 33% of the total population of Spain in 2011, respec-
tively. The daily number of hospital admissions via emergency departments only (hospital
admissions from now on) for COPD and asthma in each province from January 1st, 2003
through November 30, 2012 was obtained from the Hospital Discharge Records Database of
the Spanish National Health System (CMBD-H for its acronym in Spanish), which receives
discharge notifications from all public hospitals and private institutions within the consortium.
We examined the number of daily hospital admissions for COPD as primary diagnosis (ICD-9
490–492, 494–496) in individuals 40 years or older, and for asthma (ICD-9 493) regardless of
age. Daily population estimates in each province were calculated by linear interpolation from
population figures at the beginning of each year provided by the Spanish National Institute of
Statistics.
Daily temperatures were collected from the National Institute of Meteorology (http://
www.aemet.es/), and influenza data came from the Spanish Influenza Sentinel Surveillance
System (http://vgripe.isciii.es/gripe/inicio.do). The National Health System’s Hospital Dis-
charge Records Database (CMBD) (https://www.msssi.gob.es/estadEstudios/estadisticas/
cmbdhome.htm) provided the information on acute respiratory infections. Finally, the Span-
ish Society of=Allergology and Clinical Immunology (SEAIC for its Spanish acronym; http://
www.seaic.org/), the Spanish Aerobiology Network (REA for its Spanish acronym; http://
www.uco.es/rea/), and the Asturias Regional Health Council (https://www.asturias.es/
portal/site/astursalud/menuitem.2d7ff2df00b62567dbdfb51020688a0c/?vgnextoid=
efb82617d02e7210VgnVCM10000098030a0aRCRD) provided the data on specific pollen
counts. Relevant pollen count information was only available from five provinces in the
country, limiting the asthma admissions-related analyses to these provinces.
This study was approved by the Institutional Review Board of the Spanish Institute of
Health Carlos III (ISCIII for its acronym in Spanish). To guarantee patient confidentiality,
clinical records data were anonymized and de-identified prior to analysis.
Table 1. Summary statistics for average daily hospital admissions and other population characteristics across the fourteen largest Spanish prov-
inces, 2003–2012.
Minimum 25th percentile Median 75th percentile Maximum
Average # of daily hospital admissions
Chronic obstructive pulmonary disease* 1.3 3.7 5.6 8.1 33.1
Asthma† 0.9 1.7 5.3 8.8 9.6
Population size (thousands) 944 1,093 1,308 1,863 6,205
Population 65 years (%) 11.7 14.0 15.5 18.6 22.1
Latitude‡ (degrees north) 28.3 37.6 39.5 41.7 43.3
Human development index§ 91.3 93.1 94.2 96.1 98.8
Population unemployed (%) 9.8 10.8 13.2 18.4 22.3
Population living in rural settings¶ (%) 4.5 8.3 12.9 18.0 29.6
Number of hospital beds per 1,000 population 2.7 3.1 3.5 3.8 4.8
Number of physicians per 1,000 population 3.4 4.0 4.5 5.2 6.4
* Records from the fourteen largest Spanish provinces (Alicante, Asturias, Illes Balears, Barcelona, Ca´diz, A Coruña, Madrid, Ma´laga, Murcia, Las Palmas,
Sevilla, Valencia, Bizkaia, and Zaragoza)
† Restricted to the five provinces with pollen count information available (Asturias, Barcelona, Madrid, Murcia, and Zaragoza).
‡ Latitude of province centroid.
§ Composite index of life expectancy, education, and per capita income, with values close to 100 indicating higher levels of human development.
¶ Population living in municipalities with less than 10,000 inhabitants.
https://doi.org/10.1371/journal.pone.0177979.t001
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Province-specific analyses
We adopted a two-stage hierarchical approach [26,27] to summarize the association of smok-
ing bans with hospital admissions for chronic respiratory diseases using time-series data from
multiple Spanish provinces. In the first stage, separate Poisson additive models allowing for
overdispersion were fitted to daily data for each province to estimate changes in hospital
admission rates for COPD and asthma after the implementation of the 2006 partial and the
2011 comprehensive smoking bans adjusted for seasonality, day of the week, temperature,
influenza epidemic status, acute respiratory infection rates. Models for asthma-related admis-
sions also included pollen counts. More specifically, the number of hospital admissions for
each disease Ypt on day t in province p was assumed to follow a Poisson distribution with mean
l
p
t n
p
t and free dispersion parameter ϕp; where l
p
t was the underlying admission rate and n
p
t was
the population at risk (individuals 40 years of age for COPD and of any age for asthma). To
allow for both immediate and gradual effects of smoking bans on COPD- and asthma-related
admissions, province-specific admission rates l
p
t were analyzed through the segmented log-lin-
ear model [28]
logðlpt Þ ¼ b
p
0
þ b
p
1
t þ fbp
2
þ b
p
3
ðt   t1ÞgIðt  t1Þ
þfb
p
4
þ b
p
5
ðt   t2ÞgIðt  t2Þ þ confounders;
where t was the day indexed from day 1 (January 1st, 2003) to day 3,622 (November 30th,
2012), t1 and t2 were the days at which the partial and comprehensive smoking bans came into
effect on January 1st, 2006, and January 2nd, 2011, respectively, and I(t t1) and I(t t2) were
indicators for time periods after each smoking ban implementation. The coefficients b
p
0
and b
p
1
represented the intercept and slope of log admission rates for the 2003–2005 pre-ban period.
The coefficient b
p
2
represented the immediate shift in log admission rates at the implementa-
tion of the partial ban on January 1st, 2006; whereas b
p
3
corresponded to the change in slope of
log admission rates for the 2006–2010 partial ban period versus the pre-ban period. Similarly,
the coefficient b
p
4
represented the immediate shift in log admission rates at the implementation
of the comprehensive ban on January 2nd, 2011, whereas b
p
5
corresponded to the slope change
in log admission rates for the 2011–2012 comprehensive ban period versus the previous 2006–
2010 partial ban period. For comparison purposes, we also estimated the average daily admis-
sion rates for each calendar year by replacing the above segmented linear function of time with
single-year indicators. This allowed the display of temporal trends in province-specific admis-
sion rates without imposing any particular functional form.
Based on previous work [29], all Poisson models were adjusted for the same confounders
in all provinces and included harmonic terms for seasonality in admission rates, indicators
for the day of the week, and smoothed functions of temperature, influenza epidemic status,
and acute respiratory infection rates. Models for asthma admissions also included smoothed
functions of pollen counts. Specifically, seasonal variations were modelled by using sine and
cosine terms with both annual and semiannual periods to capture seasonal fluctuations of
higher frequency than a simple sinusoidal curve [30]. The highest temperatures, influenza
virus detection rates, number of hospital admissions for acute respiratory infections (match-
ing the age range used for each outcome), and daily pollen counts for Olea, Poaceae, and
Plantago (asthma models only) were averaged over the current day and the two previous
days. The smoothed functions of these confounders were all penalized thin plate regression
splines with a maximum of 3 degrees of freedom [31]. These splines adequately captured
potential nonlinear relationships thus leaving little residual confounding. Sensitivity analyses
with moving averages over longer lags of 0–4 days and smoothed functions with an increased
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maximum of 5 degrees of freedom provided similar control for confounding (data not
shown). Further adjustment for secular trends in smoking prevalence did not substantially
alter the results (data not shown).
To assess potential heterogeneity in the effect of smoking bans by sex and age, additional
province-specific analyses were performed separately for men and women, as well as by age
groups for COPD patients (40–64 years and 65 years) and asthma patients (< 15 years
and 15 years). All Poisson additive models were fitted using penalized quasi-likelihood
methods, as implemented in the function gam from the R package mgcv (R Foundation for
Statistical Computing; Vienna, Austria. http://www.R-project.org/).
Pooling results across provinces
In the second stage, the model coefficients estimated within each province were combined
through random-effects multivariate meta-analytic models for correlated outcomes [30]. By
doing so, we obtained a pooled estimate of the association between smoking bans and hospital
admissions for the entire country, we quantified heterogeneity in the associations across prov-
inces, and we identified province-level characteristics accounting for this heterogeneity. Spe-
cifically, the estimates bβp of the vector of true coefficients βp ¼ ðbp
1
; . . . ; b
p
5
Þ
0
defining the
province-specific linear trends in hospital admission rates during the pre-ban, partial ban, and
comprehensive ban periods were assumed to follow a multivariate normal distribution with
mean βp and estimated within-province covariance matrix Vp. This normal approximation
with accurately estimated variance was warranted by the large number of hospitalizations for
each ban period in each province (Table 1). The true coefficients βp were then allowed to vary
randomly across provinces according to a multivariate normal distribution with mean depend-
ing on province-level covariates xp ¼ ð1; xp1; . . . ; x
p
kÞ
0
and unknown unstructured between-
province covariance matrix ∑,
bβpjβp  Nðβp;VpÞ;
βpjα;Σ  NðXpα;ΣÞ;
where Xp was a block-diagonal matrix with the covariate vector xp0 repeated along the diagonal
and α was a vector of parameters relating these covariates with each coefficient in βp.
Initially, a random-effects multivariate meta-analysis [30] with no province-level covariates,
other than the intercept term xp = 1, was fitted with parameters α = (α1,. . .,α5)0 determining pop-
ulation-average linear trends for each ban period summarizing the association across all prov-
inces. The pooled percent changes in hospital admission rates at the implementation of the partial
ban and one year afterwards were estimated as 100{exp(α2)−1} and 100{exp(α2 + 365α3)−1},
respectively. Similarly, the pooled percent changes at the implementation of the comprehensive
ban and one year afterwards were defined as 100{exp(α4)−1} and 100{exp(α4 + 365α5)−1}, respec-
tively [26].
To explore potential differences in the association by province-level characteristics we
included several variables as single second-stage covariates xp = (1, xp)0 in separate random-
effects multivariate meta-regression models [30]. These variables included: geographical lati-
tude, human development index (a composite index of life expectancy, education, and per cap-
ita income), percentage of population unemployed, percentage of population living in rural
settings, and number of hospital beds and physicians per 1,000 population in each province.
Modifications of pooled ban effects by these province-level characteristics were contrasted
through likelihood ratio tests comparing nested meta-regression models with and without the
covariate.
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The overall heterogeneity in the association across provinces, as well as the residual hetero-
geneity beyond that explained by province-level characteristics, were detected with the multi-
variate extension of the Cochran chi-squared test and quantified with the extended I2 statistic.
The I2 statistic describes the proportion of total variation in estimates bβp, i.e., it depicts the pro-
portion of total variation in the derived province-specific associations due to heterogeneity
[26,32]. The above random-effects multivariate meta-analysis and meta-regression models
were fitted through maximum likelihood methods using the R package mvmeta (R Foundation
for Statistical Computing).
Results
During the entire study period there were 431,797 hospital admissions for COPD in the four-
teen largest Spanish provinces, as well as 95,411 hospital admissions for asthma in five prov-
inces. By province, the average number of daily hospitalizations varied from 1.3 to 33.1 for
COPD, and from 0.9 to 9.6 for asthma (Table 1). The province-specific daily hospital admis-
sion rates by single calendar year are displayed in Fig 1. Compared to asthma-related admis-
sions, declines in COPD-related admission rates were more pronounced and heterogeneous
across provinces, with an average decrease of 3.6% per year. The hospitalization rates for
asthma remained fairly stable.
Overall pooled associations of smoking bans on hospital admission rates
Linear trends in hospital admission rates during the pre-ban, partial-ban, and comprehensive-
ban periods varied widely across provinces (Fig 2). Over 90% of the variability in the estimated
segmented linear trends was due to in-between province heterogeneity (I2 = 98.2% for COPD
and 93.8% for asthma; all P values< 0.001). The pooled segmented linear trends across all
provinces are displayed in Fig 2 and the corresponding pooled changes in hospital admission
Fig 1. Daily hospital admission rates for chronic obstructive pulmonary disease and asthma by single calendar year in selected Spanish
provinces, 2003–2012. Average daily admission rates for each calendar year were obtained from overdispersed Poisson additive models with single-
year indicators and adjusted for seasonality, day of the week, temperature, influenza epidemics, acute respiratory infections, and pollen counts for
asthma-related admissions (only available in Asturias, Barcelona, Madrid, Murcia, and Zaragoza). Rates refer to 1,000,000 population 18 years for
cardiovascular diseases, 40 years for chronic obstructive pulmonary disease, and all ages for asthma. Vertical dashed lines represent the dates at
which the partial and comprehensive smoking bans entered into force on January 1st, 2006, and January 2nd, 2011, respectively.
https://doi.org/10.1371/journal.pone.0177979.g001
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rates after the implementation of the partial and the comprehensive bans are summarized in
Table 2.
The partial smoking ban was associated with a strong significant pooled immediate decline
of 14.7% in COPD-related admission rates, which was sustained over time with a one-year
13.6% decrease. There was no subsequent effect of the comprehensive ban on COPD-related
admission rates (immediate and one-year changes of -0.9% and 3.0%, respectively). After
the partial ban, both sexes experienced the aforementioned strong pooled decline in COPD-
related admissions (Table 2), though rates among women were partially offset by a subsequent
increase (non-statistically significant (ns)) after the comprehensive ban (immediate and one-
year increases of 6.4% and 8.4%, respectively). The sharp pooled declines in COPD-related
admissions at the onset and the first year of the partial ban were observed both in middle-aged
and elderly subjects (Table 2).
Asthma-related admission rates increased by 12.1% immediately after the partial ban, but
decreased by 7.4% after the comprehensive ban, though these pooled estimates were highly
imprecise. Also, the pooled rise in asthma-related admissions after the partial ban (immediate
increases of 14.8% in men and 10.3% (ns) in women) was fully offset in men with the imple-
mentation of the comprehensive ban (an immediate decrease of 17.4%) but not in women (an
immediate decrease of 3.5% (ns)).
Pooled effects of smoking bans on hospital admission rates by province-
level characteristics
Table 3 shows pooled changes in COPD-related admission rates by province-level characteris-
tics. There were significant modifications of the magnitude of the partial smoking ban
Fig 2. Population-average and province-specific segmented linear trends in hospital admission rate ratios for chronic obstructive
pulmonary disease and asthma in selected Spanish provinces, 2003–2012. Province-specific segmented linear trends in hospital admission rate
ratios (gray lines) were obtained from overdispersed Poisson additive models with distinct linear segments within the 2003–2005 pre-ban, 2006–2010
partial ban, and 2011–2012 comprehensive ban periods, and adjusted for seasonality, day of the week, temperature, influenza epidemics, acute
respiratory infections, and pollen counts for asthma-related admissions (only available in Asturias, Barcelona, Madrid, Murcia, and Zaragoza). Pooled
segmented linear trends (bold black lines) were obtained from random-effects multivariate meta-analyses on province-specific estimates of segmented
regression coefficients. The reference time point (rate ratio = 1) was set at the midpoint pre-ban period (July 1st, 2004). Vertical dashed lines represent
the dates at which the partial and comprehensive smoking bans entered into force on January 1st, 2006, and January 2nd, 2011, respectively.
https://doi.org/10.1371/journal.pone.0177979.g002
Changes in hospitalizations for chronic respiratory diseases after two smoking bans in Spain
PLOS ONE | https://doi.org/10.1371/journal.pone.0177979 May 24, 2017 7 / 14
associations on COPD-related admission rates by human development index (P for effect
modification = 0.04), percentage of population unemployed (P = 0.05), and percentage of rural
population (P = 0.02). Both the immediate and one-year pooled declines in COPD-related
admission rates reached 16.6% following the partial ban in provinces with a relatively low
human development level (25th percentile). In provinces with a high unemployment rate
(75th percentile), immediate and one-year rates declined 18.3% and 20.1%, respectively.
Finally, in provinces with a relatively high percentage of rural population (75th percentile)
rates decreased 19.2% and 18.4%, respectively. However, these factors contributed little to the
high heterogeneity observed in COPD-related admission trends across provinces (all residual
I2>97%). Effect modifications for asthma-related admissions were not explored due to the lim-
ited number of meta-analyzed provinces.
Discussion
The implementation of the first smoking regulation, a partial ban, was associated with a strong
immediate decline in COPD-related hospital admissions. This reduction persisted all through-
out the regulation years experiencing only modest changes when the second smoking law, a
comprehensive ban, came into force. The observed association is consistent across age and sex
groups but stronger in less economically developed Spanish provinces.
Table 2. Pooled changes in hospital admission rates for chronic obstructive pulmonary disease and asthma immediately after and at the one-year
mark of the implementation of the 2006 partial and 2011 comprehensive smoking bans, by sex and age group in selected Spanish provinces,
2003–2012*.
2006 partial smoking ban† 2011 comprehensive smoking ban‡ I2§
(%)Immediate percent
change (95% CI)
One-year percent
change (95% CI)
Immediate percent
change (95% CI)
One-year percent
change (95% CI)
Chronic obstructive
pulmonary disease¶
Overall -14.7 (-23.4, -5.0) -13.6 (-23.1, -2.9) -0.9 (-4.4, 2.8) 3.0 (-5.4, 12.1) 98.2
Men -15.6 (-23.5, -6.9) -15.9 (-24.4, -6.5) -2.1 (-5.9, 2.0) 2.5 (-6.1, 11.8) 97.9
Women -16.8 (-28.3, -3.4) -13.6 (-27.1, 2.4) 6.4 (-0.1, 13.2) 8.4 (-0.9, 18.5) 94.2
40–64 years -17.3 (-26.7, -6.8) -14.5 (-24.3, -3.4) -2.8 (-9.6, 4.6) -2.4 (-10.4, 6.4) 94.5
 65 years -14.8 (-23.5, -5.1) -15.7 (-25.4, -4.6) -1.4 (-5.3, 2.7) 3.4 (-5.3, 13.0) 97.7
Asthma**
Overall 12.1 (-3.2, 29.8) 19.1 (-2.3, 45.1) -7.4 (-14.2, -0.2) -2.7 (-6.9, 1.6) 93.8
Men 14.8 (1.4, 30.0) 22.4 (11.0, 35.0) -17.4 (-26.2, -7.6) -9.9 (-15.6, -3.9) 89.3
Women 10.3 (-4.5, 27.4) 16.1 (-5.9, 43.3) -3.5 (-10.2, 3.7) -0.7 (-5.2, 3.9) 93.2
< 15 years 25.0 (-2.6, 60.4) 30.4 (4.9, 62.0) -11.0 (-28.6, 11.1) -1.1 (-14.3, 14.2) 93.1
 15 years 8.6 (-4.9, 24.0) 18.3 (-3.3, 44.8) -4.0 (-11.5, 4.0) -3.2 (-7.9, 1.7) 91.2
* Province-specific segmented linear trends in hospital admission rates were first obtained from overdispersed Poisson additive models with distinct linear
segments within the 2003–2005 pre-ban, 2006–2010 partial ban, and 2011–2012 comprehensive ban periods, and then combined across provinces
through random-effects multivariate meta-analyses.
† Pooled percent changes in hospital admission rates and their 95% confidence intervals (CIs) at the implementation and one-year following the partial ban
compared with the projected trend from the pre-ban period.
‡ Pooled percent changes in hospital admission rates and their 95% CIs at the implementation and one year following the comprehensive ban compared
with the projected trend from the previous partial ban period.
§ Overall I2 statistic for heterogeneity in ban effects across provinces.
¶ Pooled changes across the largest fourteen provinces (Alicante, Asturias, Illes Balears, Barcelona, Ca´diz, A Coruña, Madrid, Ma´laga, Murcia, Las Palmas,
Sevilla, Valencia, Bizkaia, and Zaragoza)
**Pooled changes across the five provinces with pollen count information available (Asturias, Barcelona, Madrid, Murcia, and Zaragoza).
https://doi.org/10.1371/journal.pone.0177979.t002
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Existing evidence of the impact of implementing smoke-free legislation on COPD-related
hospital admissions remains scarce and results are inconsistent. Some studies report a decrease
in admissions [8–13], whereas others failed to detect any changes [14–16]. There is a wide vari-
ation in strength of association reported in positive studies. The rate reduction detected in this
work is similar to that reported by Vander Weg and colleagues [13] in the United States, and
Dusemund and colleagues in Switzerland [6]. This reduction in COPD-related hospital admis-
sions is larger than the reduction observed for heart ischemic diseases [33].
Our segmented-linear models allowed us to differentiate between the associations
observed right after the law´s execution (immediate association) and those taking place over
Table 3. Pooled changes in hospital admission rates for chronic obstructive pulmonary disease (COPD) immediately after and at the one-year
mark of the implementation of the 2006 partial and 2011 comprehensive smoking bans by characteristics of the fourteen largest Spanish prov-
inces, 2003–2012*.
25th and 75th percentiles
of province-level
characteristic
2006 partial smoking ban† 2011 comprehensive smoking ban‡ p-value for effect
modification§
I2 for residual
heterogeneity¶ (%)Immediate
percent change
(95% CI)
One-year
percent change
(95% CI)
Immediate
percent change
(95% CI)
One-year
percent change
(95% CI)
Latitude (degrees north) 0.31 98.1
37.6 -15.5 (-24.8, -5.0) -15.3 (-25.3,
-4.0)
1.9 (-2.0, 6.0) 6.6 (-2.0, 15.9)
41.7 -12.9 (-23.4, -1.0) -10.6 (-22.0, 2.5) -3.3 (-6.6, 0.2) -1.2 (-9.8, 8.2)
Human development index 0.04 97.4
93.1 -16.6 (-27.0, -4.8) -16.6 (-27.6,
-4.0)
0.7 (-4.1, 5.6) 10.9 (1.9, 20.6)
96.1 -12.6 (-22.9, -0.9) -10.3 (-21.5, 2.4) -2.0 (-5.7, 1.9) -3.2 (-10.5, 4.6)
Population unemployed (%) 0.05 97.6
10.8 -11.0 (-22.4, 2.0) -7.1 (-19.2, 6.9) -3.0 (-7.1, 1.2) -6.6 (-13.2, 0.5)
18.4 -18.3 (-29.3, -5.5) -20.1 (-31.2,
-7.1)
2.2 (-3.4, 8.1) 15.5 (6.5, 25.4)
Rural population (%) 0.02 98.2
8.3 -8.0 (-18.8, 4.1) -6.5 (-18.2, 7.0) 0.9 (-3.6, 5.6) 6.6 (-4.2, 18.6)
18.0 -19.2 (-27.8, -9.5) -18.4 (-27.7,
-7.9)
-2.2 (-6.2, 2.0) 0.5 (-8.8, 10.7)
# of hospital beds per 1,000
population
0.32 98.1
3.1 -12.0 (-22.8, 0.2) -13.5 (-25.1,
-0.1)
0.0 (-4.5, 4.6) 8.8 (-0.8, 19.3)
3.8 -16.6 (-25.9, -6.0) -13.7 (-24.3,
-1.5)
-1.4 (-5.2, 2.5) -1.0 (-9.0, 7.7)
# of physicians per 1,000
population
0.55 98.2
4.0 -15.4 (-26.2, -3.0) -14.2 (-26.0,
-0.5)
-0.7 (-5.4, 4.3) 7.3 (-3.1, 18.8)
5.2 -13.9 (-24.3, -2.0) -12.8 (-24.1, 0.2) -1.0 (-5.1, 3.1) -0.5 (-9.5, 9.5)
* Pooled changes by province-level characteristics were obtained from separate random-effects multivariate meta-regression models relating province-
specific estimates of segmented regression coefficients with their values of the corresponding characteristic as a single continuous covariate.
† Pooled percent changes in hospital admission rates and their 95% confidence intervals (CIs)at the implementation and one year following the partial ban,
compared with the projected trend from the pre-ban period, for the 25th and 75th percentiles of the province-level characteristic.
‡ Pooled percent changes in hospital admission rates and their 95% CIs at the implementation and one year following the comprehensive ban, compared
with the projected trend from the previous partial ban period, for the 25th and 75th percentiles of the province-level characteristic.
§ Overall P value for modification of pooled ban effects by the corresponding province-level characteristic.
¶ Overall I2 statistic for residual heterogeneity in province-specific ban effects not explained by the corresponding province-level characteristic.
https://doi.org/10.1371/journal.pone.0177979.t003
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the medium-term. Thus, we were able to observe that the onset of the partial ban was associ-
ated with a rapid reduction in COPD-related hospital admissions. These results are consis-
tent with the fast-acting harmful effects of SHS such as reduced pulmonary function and
increased inflammatory processes, which have been observed even at low levels of exposure
[34].
The current project´s pilot study evaluated the effect of the partial smoking ban on hospital
admissions in the two largest Spanish cities, Madrid and Barcelona [29]. That study revealed
that controlling for seasonality and related variables, such as flu and respiratory infection epi-
demics, had a moderate effect on hospital admission rate changes. In fact, in the time series,
the 2005 COPD increase could be related to the strong flu epidemic of that same year [35]
which may have brought forward the hospital admissions of the most vulnerable portion of the
population, resulting, in turn, in a reduction in admissions in the following months, a pattern
known as “harvesting effect.” Thus, we cannot rule out the possibility that the fall in admis-
sions immediately following the ban´s implementation may be related to the previous year´s
flu epidemic. However, the impact of this “harvesting effect” has proven small and limited in
time (i.e., months) in relation to mortality [36]. Additionally, if admissions had been moved
up, one would expect a subsequent gradual increase until reaching pre-2005 rates. In contrast,
for the 5 years the partial ban was in place the slope representing number of admissions is par-
allel to the slope for the reference period (2003–2005), i.e., the effect remains consistent.
Regarding asthma-related hospital admissions, most authors report a decline in hospital
admissions [10,12,16–21] and emergency department visits [14,22], although two other studies
[11,15] failed to detect a favorable impact on hospitalizations. Unfortunately, our asthma-
related results are not conclusive. In contrast with COPD-related results, the onset of the first
ban is not related to a decrease in admissions but our data show a significant reduction in
admissions immediately following the implementation of the comprehensive ban. However,
this favorable change is maintained after one year only among men. Asthma is a highly hetero-
geneous condition presenting several phenotypes and widely differing epidemiological pat-
terns by sex. Child population studies show that the effect of SHS exposure on respiratory
function is far greater in boys than in girls, probably as a result of the faster bronchial develop-
ment in girls [37]. Unfortunately, our study lacks the statistical power necessary for sex-strati-
fied analyses for those under 15 years of age. Further research is needed in this area.
It is worth highlighting here the great variability in estimates across provinces for both
COPD- and asthma-related admissions. This heterogeneity has been previously described by
Tan and colleagues when comparing studies performed in different countries [33] as well asin
a study on myocardial infarction morbidity and mortality based on a large sample of U.S.
regions [38]. In this work, we were able to examine sources of variability only for COPD-
related admissions given the small number of provinces included in the asthma-related analy-
ses. A highly interesting find is the greater effect of the bans observed in provinces with lower
levels of socioeconomic development, an understudied area of research. As far as we know,
only one study carried out in Ireland has examined socioeconomic differentials in the impact
of a national smoking ban on COPD mortality [39]. The authors detected the most pro-
nounced COPD-related mortality reductions in the most disadvantaged tertile of the popula-
tion. On the one hand, this finding is consistent with the knowledge that COPD is a disease
strongly associated to socioeconomic status, being twice as prevalent among individuals of low
socioeconomic level [40]. On the other hand, low socioeconomic level individuals are more
likely to have greater SHS exposure [41] and, thus, are more likely to benefit from a reduction
of SHS exposure in public spaces than other groups.
Nevertheless, residual variance remains very high, and it is likely that other variables,
such as regional variability in compliance with the bans, may be related to differing rates of
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respiratory conditions-related hospital admissions. Estimates of police reports and sanctions
by region varied widely from the time the partial ban was put in place, though compliance
with the law cannot be compared due to the absence of official statistics [42].
Overall, more benefits on cardiovascular and respiratory diseases are observed in regions
with comprehensive smoking laws banning smoking at the workplace as well as in bars and
restaurants [33]. In fact, a U.S. study concluded that living in a community with a compre-
hensive smoke-free law reduced the risk of hospitalizations for COPD compared to living
under a moderate-weak law [9]. However, current evidence includes important inconsisten-
cies: three studies found reductions in COPD admissions in the context of partial laws
[8,11,13], whereas three of the five studies evaluating comprehensive laws, failed to find a
protective effect [14–16] and the other two showed an association [9,10]. Further, the one
study evaluating asthma-related admissions under a partial ban failed to detect any effect
[11]. Further research is required to identify how smoke-free policies may have differential
effects on the disease burden of these two pathologies. For instance, given low rates of
asthma-related hospital admissions compared to the high disease prevalence at the popula-
tion level, primary care and emergency room visits might better capture the effects of smok-
ing bans. These measures may be more relevant in the case of asthma because SHS exposure
increases healthcare visits among non-severe cases [43].
However, despite both diseases being highly prevalent at the population level, not only
COPD-related hospital admissions are far more common than asthma-related ones but one
third of hospitalized patients is at risk of re-admission within 90 days, especially those with
severe disease and high comorbidity [44]. Thus, COPD, as a condition sensitive enough to
smoke-free policies, may be an suitable indicator to measure the effects of introducing non-
comprehensive regulations. As far as we know only the Toronto (Canada) study by Naiman
and colleagues [12] has evaluated the implementation of smoke-free policies in in three dis-
tinct phases. The first phase affected only the workplace environment including government
offices; the second phase extended the ban to restaurants; and the final phase further extended
the prohibition to bars. Reductions in hospital admission rates related to COPD and asthma
were observed only after the second phase was implemented.
Our results should be interpreted in the context of the study’s limitations. The main one
pertains to the ecological nature of the study which precludes the inference of causality. Addi-
tionally, simultaneous country-wide implementation of the regulations eliminated the possi-
bility of a control group for comparisons.
Other limitations include the lack of information on patients´ smoking status on admis-
sion records. Further, despite adjusting for highly relevant covariates, changes in other fac-
tors not accounted for such as improvements in disease management during the period
under study may have influenced our estimates, although any improvements are likely to
have been too gradual to have any significant effect. Similarly, there might have been regis-
try-related administrative factors affecting hospital admissions regarding these diseases.
However, we are unaware of any such changes. Regarding asthma-related results for chil-
dren, we only had the required data on specific pollen counts for five provinces, thus, limit-
ing the statistical power necessary for sex-stratified analyses for those under 15 years of age.
Larger samples are needed to further research in this area. Finally, meta-regression results
are prone to low power issues and ecological bias when examining aggregate measures of
individual-level characteristics.
Major strengths of this study include the analysis of a large sample including the fourteen
largest Spanish regions and the availability of a large number of covariates modeled based on
daily observations. The richness of these data allowed the creation of separate models for each
province as well as by age and sex groups.
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Conclusions
The implementation of the first partial smoking ban is associated with a 14.7% decrease in
COPD-related hospital admissions. This reduction remained steady and, basically, unaffected
by the introduction of the comprehensive smoking ban. This association is consistent across
sex and age groups and stronger in less economically developed provinces than in those with
stronger economies. Unfortunately, asthma-related results are not conclusive. An immediate
reduction in hospital admissions was observed after the implementation of the comprehensive
ban. However, the reduction was sustained only for one year and only in men.
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